Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is QUINAPRIL HYDROCHLORIDE USP, with a corresponding US DMF Number 20315.
Remarkably, this DMF maintains an Active status since its submission on October 17, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 23, 2013, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II